Interviews

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses potential opportunities for specialty pharmacies as technology continues to evolve.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses which drugs are expected to dominate the market in 2017.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, lists the strategies pharmacy benefit managers use to reduce spending on opioids.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses the importance of a quick turnaround from patient referral to acceptance.

Marc O’Connor, chief operating officer at Curant Health, explains ways patient care models can reduce costs.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how stakeholder alliances benefit patients.

In this video, Tripp Logan, PharmD, explains how pharmacists can establish solid relationships with other providers to maximize the management of patients' diabetes.

In this clip, Tripp Logan, PharmD, discusses the role that community pharmacists play in ensuring that patients are receiving the most optimized therapies for them and considering future outcomes.

In this video, Dhiren Patel, PharmD, Associate Professor of Pharmacy Practice at the Massachussetts School of Pharmacy, explains the importance of collaboration between pharmacists and other providers in the management of their patients' diabetes care.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, discusses how proposed legislations would affect pharmacy benefit manager relations with specialty pharmacies.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the importance of specialty pharmacists becoming certified and how it improves the industry as a whole.

Joel Wright, chief executive officer, AllianceRx Walgreens Prime discusses how specialty pharmacies can leverage retail pharmacies connections to negotiate costs.

Moses Zonana, CEO of Compliance Meds Technologies, discusses the impact of medication nonadherence.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, discusses how Walgreens has encouraged their pharmacists to continue their education.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, discusses what considerations must be made to create a care management program in the specialty space.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses how to improve patient outcomes and decrease oncology spend.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses why streamlining specialty pharmacy care is important.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the importance of disruption.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, takes a legal perspective on direct and indirect remuneration fees and how they affect specialty pharmacies.

Marc O’Connor, chief operating officer, Curant Health, discusses the best ways for pharmacies to succeed in the shift to value-based care.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses what pharmacy benefit managers look for in a specialty pharmacy.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime speaks to how medication synchronization programs can improve adherence.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses promising specialty drugs to watch out for in the pipeline.

Marc O’Connor, chief operating officer at Curant Health, discusses the benefits of disruption within the specialty landscape.

David DeRemer, PharmD, Assistant Director of Clinical Therapeutics and Incubator, Clinical Associate Professor at the University of Florida College of Pharmacy, discusses resources to help educate patients on oral chemotherapy agents.

As a part of the continuing effort to increase awareness and celebrate the pharmacy profession, Pharmacy Times and Specialty Pharmacy Times are partnering to launch the #APharmacistIs campaign.